clinical research studies for adults and children with congenital adrenal hyperplasia (CAH)
If you or your child has congenital adrenal hyperplasia, the CAH Studies may be of interest to you.
The primary purpose of these clinical research studies is to evaluate the safety and effectiveness of an investigational medication in adults and children with classic congenital adrenal hyperplasia. Participation in the CAHtalyst Study lasts approximately 20 months. Participation in the CAHtalyst Pediatric Study lasts approximately 60 weeks.
To learn more, visit CAHStudies.com.
The primary purpose of these clinical research studies is to evaluate the safety and effectiveness of an investigational medication in adults and children with classic congenital adrenal hyperplasia. Participation in the CAHtalyst Study lasts approximately 20 months. Participation in the CAHtalyst Pediatric Study lasts approximately 60 weeks.
To learn more, visit CAHStudies.com.